Search
Elicio Therapeutics Inc
ELTXAdd to Watchlist
5.140USD
+1.230+31.46%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
98.10MMarket Cap
LossP/E TTM
Elicio Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-01The current valuation score of Elicio Therapeutics Inc is 8.66, ranking 96 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.17, which is -818.75% below the recent high of 15.60 and -188.92% above the recent low of -6.27.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.